FLRY3.SA
Healthcare Diagnostics & ResearchFleury S.A.
R$26.00
+0.67 +2.65% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 10:47 AM ET | 26.00 |
Key Stats
Market Cap
14.13B
Avg Volume
3.78M
P/E (TTM)
22.41
EPS
R$1.16
52W High
R$26.07
52W Low
R$13.90
Div. Yield
4.8%
Analyst Ratings
Hold1
Str Buy
2
Buy
7
Hold
0
Sell
2
Str Sell
Valuation
Forward P/E
15.59
P/B Ratio
2.83
P/S Ratio
1.61
EV/EBITDA
8.53
EV/Revenue
1.92
Margins
Gross Margin 27.1%
Operating Margin 17.1%
Net Margin 8.0%
EBITDA Margin 22.5%
Growth & Returns
Revenue Growth (YoY)
14.4%
Earnings Growth (QoQ)
45.7%
Return on Equity
12.6%
Return on Assets
6.5%
Liquidity & Leverage
Current Ratio
1.86
Quick Ratio
1.74
Debt / Equity
0.98
Total Cash
1.90B
Total Debt
5.41B
About
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
ri.fleury.com.br